CLINICAL TRIAL RECRUITMENT FOR ABBV-744 STUDY FUNDAMENTALS EXPLAINED

In Segment A, contributors will get diverse doses and schedules of oral ABBV-744 tablet to recognize Safe and sound dosing routine. Added individuals will likely be enrolled in the discovered monotherapy dosign routine. In Segment B, contributors will obtain oral ruxolitinib and ABBV-744 will likely be offered as "add-on" therapy. In Section C, par